|
On
September 22, the Food and Drug Administration (FDA) amended of the
emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine
to allow for use of a single booster dose to be administered at least six
months after completion of the primary series for:
- individuals 65 years of age and
older;
- individuals 18 through 64 years
of age at high risk of severe COVID-19; and
- individuals 18 through 64 years
of age whose frequent institutional or occupational exposure to
SARS-CoV-2 puts them at high risk of serious complications of COVID-19
including severe COVID-19.
More
information on the FDA’s authorization can be found
here.
Additionally,
on September 24, the Centers for Disease Control and Prevention (CDC)
recommended:
·
people 65 years and
older and residents in long-term care settings should receive a
booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their
Pfizer-BioNTech primary series,
·
people aged 50–64
years with underlying medical conditionsshould receive a
booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months
after their Pfizer-BioNTech primary series,
·
people aged 18–49
years with underlying medical conditionsmay receive a booster
shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their
Pfizer-BioNTech primary series, based on their individual benefits and
risks, and
·
people aged 18-64
years who are at increased risk for COVID-19 exposure and transmission
because of occupational or institutional setting may receive a
booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after
their Pfizer-BioNTech primary series, based on their individual benefits
and risks.
More
information on the CDC’s recommendations can be found here.
As a
reminder, in accordance with the American Rescue Plan Act of 2021 (ARP),
nearly all Medicaid and CHIP beneficiaries must receive coverage of
COVID-19 vaccines and their administration, including these boosters,
without cost-sharing. People can visit vaccines.gov (English) or
vacunas.gov (Spanish) to search for vaccines nearby.
CMS
will release an updated Coverage and Reimbursement of COVID-19 Vaccines,
Vaccine Administration, and Cost Sharing under Medicaid, the Children’s
Health Insurance Program, and Basic Health Program toolkit in the near
future to reflect this and other relevant updates.
·
Learn more here: https://www.cms.gov/newsroom/press-releases/cms-will-pay-covid-19-booster-shots-eligible-consumers-can-receive-no-cost
|
No comments:
Post a Comment